Gadolinium Lawyer

The U.S. Food and Drug Administration (FDA) have asked manufacturers of all gadolinium-based contrast agents to include a new boxed warning on the product labeling. These agents are used to enhance the quality of magnetic resonance imaging (MRI).The warning states that patients with severe kidney insufficiency are at risk for developing a debilitating, and a […]

[Read more →]

As news regarding the dangers of gadolinium continues to hit the wires, an interesting piece was published just yesterday on Doctor’s Guide, which told the story of how one of the manufacturers of a contrasting agent that contains gadolinium has issued a warning letter to health care professionals regarding the inherent dangers of the substance.
“Manufacturers […]

[Read more →]

Is there any other time this drug gadolinium used other than for a MRI?
******************************************************************
No, it’s primary use is as a constrast agent in MRIs.  To learn more, please contact Gadolinium Lawyers at Williams Kherkher at 1.800.220.9341.

[Read more →]

Some patients who are on kidney dialysis develop a condition termed nephrogenic systemic fibrosis (NSF).   This condition leads to thickened, rough or hard skin, usually on the arms legs or trunk.  In some cases the condition becomes so sever the limbs can be difficult or even impossible to move.
Recent research has indicated NSF is possibly […]

[Read more →]

Sometimes in MRI (”magnetic resonance imaging”) and always in MRA (”magnetic resonance angiography”) a contrast dye may be injected into the body to help detect any abnormalities. MRI and MRA contrast dye containing the heavy metal gadolinium has been linked to a disease called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermotherapy (NFD). 
This is a life […]

[Read more →]